1. 1087. Imipenem-Cilastatin-Relebactam (I/R) Pharmacokinetics (PK) in Critically Ill Patients with Augmented Renal Clearance (ARC). (4th December 2021) Authors: Fratoni, Andrew J; Mah, John W; Nicolau, David P; Kuti, Joseph L Journal: Open forum infectious diseases Issue: Volume 8(2021)Supplement 1 Page Start: S635 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 1087. Imipenem-Cilastatin-Relebactam (I/R) Pharmacokinetics (PK) in Critically Ill Patients with Augmented Renal Clearance (ARC). (4th December 2021) Authors: Fratoni, Andrew J; Mah, John W; Nicolau, David P; Kuti, Joseph L Journal: Open forum infectious diseases Issue: Volume 8(2021)Supplement 1 Page Start: S635 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. 1103. Minocycline (MIN) Pharmacodynamics (PD) against Stenotrophomonas maltophilia (STM) in a Neutropenic Murine Thigh Infection Model. (4th December 2021) Authors: Fratoni, Andrew J; Nicolau, David P; Kuti, Joseph L Journal: Open forum infectious diseases Issue: Volume 8(2021)Supplement 1 Page Start: S643 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. 1103. Minocycline (MIN) Pharmacodynamics (PD) against Stenotrophomonas maltophilia (STM) in a Neutropenic Murine Thigh Infection Model. (4th December 2021) Authors: Fratoni, Andrew J; Nicolau, David P; Kuti, Joseph L Journal: Open forum infectious diseases Issue: Volume 8(2021)Supplement 1 Page Start: S643 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. 1722. In vivo Activity of Imipenem/XNW4107 Human-Simulated Regimen against Serine Carbapenemase-Producing Acinetobacter baumannii and Pseudomonas aeruginosa in the Neutropenic Murine Thigh Infection Model. (15th December 2022) Authors: Fratoni, Andrew J; Berry, Angela; Yuan, Haitao; Liu, Xiao; Chen, Xi; Wu, Yuchuan; Nicolau, David P; Abdelraouf, Kamilia Journal: Open forum infectious diseases Issue: Volume 9:(2022)Supplement 2 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. 626. Tebipenem Pharmacokinetics and Soft-Tissue Distribution in Diabetic Patients with Lower Extremity Infections using In Vivo Microdialysis. (15th December 2022) Authors: Abouelhassan, Yasmeen; Fratoni, Andrew J; Shepard, Ashley; Nicolau, David P; Asempa, Tomefa E Journal: Open forum infectious diseases Issue: Volume 9:(2022)Supplement 2 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. 65. In Vivo Efficacy of Human Simulated Minocycline (MIN) against Stenotrophomonas maltophilia (STM). (4th December 2021) Authors: Fratoni, Andrew J; Nicolau, David P; Kuti, Joseph L Journal: Open forum infectious diseases Issue: Volume 8(2021)Supplement 1 Page Start: S44 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Imipenem/cilastatin/relebactam pharmacokinetics in critically ill patients with augmented renal clearance. (30th July 2022) Authors: Fratoni, Andrew J; Mah, John W; Nicolau, David P; Kuti, Joseph L Journal: Journal of antimicrobial chemotherapy Issue: Volume 77:Number 11(2022) Page Start: 2992 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Impact of a Pharmacist-Managed Procalcitonin Program on COVID-19 Respiratory Tract Infection Outcomes and Health Care Resource Utilization. (11th September 2022) Authors: Fratoni, Andrew J; Kois, Abigail K; Colmerauer, Jessica L; Linder, Kristin E; Nicolau, David P; Kuti, Joseph L Journal: Open forum infectious diseases Issue: Volume 9:Number 9(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. In vivo pharmacokinetics and pharmacodynamics of ceftibuten/ledaborbactam, a novel oral β-lactam/β-lactamase inhibitor combination. (22nd October 2022) Authors: Fratoni, Andrew J; Avery, Lindsay M; Nicolau, David P; Asempa, Tomefa E Journal: Journal of antimicrobial chemotherapy Issue: Volume 78:Number 1(2023) Page Start: 93 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗